MORF-057

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	3

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05611671 (ClinicalTrials.gov)	October 31, 2022	31/10/2022	A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC	A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy o ...	Inflammatory Bowel Diseases;Colitis, Ulcerative	Drug: MORF-057;Drug: Placebo	Morphic Therapeutic, Inc	NULL	Recruiting	18 Years	85 Years	All	280	Phase 2	United States;Australia
2	EUCTR2021-005288-31-PL (EUCTR)	04/07/2022	19/05/2022	A Phase 2a study to evaluate the Efficacy, Safety, and Tolerability of MORF-057in Ulcerative Colitis ...	A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF- ...	Moderate to Severe Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;T ...	Product Name: MORF-057 Product Code: MORF-057 INN or Proposed INN: MORF-057 Other descriptive name: MOR ...	Morphic Therapeutic, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	35	Phase 2	United States;Poland
3	NCT05291689 (ClinicalTrials.gov)	May 24, 2022	10/3/2022	A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC	A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF- ...	Inflammatory Bowel Diseases;Colitis, Ulcerative	Drug: MORF-057	Morphic Therapeutic, Inc	NULL	Recruiting	18 Years	85 Years	All	40	Phase 2	United States;Poland

First Previous1Next Last